[Progress and results in the treatment of multiple myeloma]

[A rare cause of pulmonary-renal syndrome with autoantibodies: primary antiphospholipid syndrome].

Nephrologie·2004

Inflammatory myositis associated with anti-U1-small nuclear ribonucleoprotein antibodies: a subset of myositis associated with a favourable outcome.

Rheumatology (Oxford, England)·2002

Effectiveness of platelet transfusions after plasma exchange in adult thrombotic thrombocytopenic purpura: a report of two cases.

American journal of hematology·2002

HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression.

AIDS research and human retroviruses·2001

Diffuse large B-cell non-Hodgkin's lymphoma in a patient with autoimmune lymphoproliferative syndrome.

British journal of haematology·2001

Lack of evidence of a specific role for C4A gene deficiency in determining disease susceptibility among C4-deficient patients with systemic lupus erythematosus (SLE).

Clinical and experimental immunology·2001

[Oncogenetics and molecular tumor boards in private practice: Specificities and perspectives].

Bulletin du cancer·2026

Targeting TP53 in triple-negative breast cancer: Molecular pathogenesis, therapeutic implications, and emerging pharmacological strategies.

Bulletin du cancer·2026

French treatment recommendations for malignant non-seminomatous germ cell tumours in children and adolescents.

Bulletin du cancer·2026

A comprehensive review on the molecular basis and therapeutic potential of UBE2M in cancer.

Bulletin du cancer·2026

Cervical cancer in French Guiana before the implementation of the University Hospital: Outcome and prognosis.

Bulletin du cancer·2026

[Metastatic or unresectable recurrent anal canal cancer: Therapeutic approaches and emerging perspectives].

Bulletin du cancer·2026

Clinical Efficacy of High-Frequency Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Depression and the Predictive Role of Baseline Triglyceride Levels: A Randomized Sham-Controlled Trial.

Clinical EEG and neuroscience·2026

Mechanistic Basis and Therapeutic Potential of a Novel TXNIP Inhibitor in Diabetes Treatment.

Journal of medicinal chemistry·2026

Discovery of BRD9 PROTAC/IMiD Bifunctional Molecules as Potent Therapeutics for Hematologic Malignancies.

Journal of medicinal chemistry·2026

First line asciminib in chronic myeloid leukemia: a quest for the "Holy Grail" of tolerability.

Haematologica·2026

Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition.

Haematologica·2026

Repurposing MK0873 as a non-covalent hTERT-Targeting compound: a proof of concept study.

Frontiers in aging·2026

Related Experiment Videos

[Progress and results in the treatment of multiple myeloma]

Related Concept Videos

[A rare cause of pulmonary-renal syndrome with autoantibodies: primary antiphospholipid syndrome].

Inflammatory myositis associated with anti-U1-small nuclear ribonucleoprotein antibodies: a subset of myositis associated with a favourable outcome.

Effectiveness of platelet transfusions after plasma exchange in adult thrombotic thrombocytopenic purpura: a report of two cases.

HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression.

Diffuse large B-cell non-Hodgkin's lymphoma in a patient with autoimmune lymphoproliferative syndrome.

Lack of evidence of a specific role for C4A gene deficiency in determining disease susceptibility among C4-deficient patients with systemic lupus erythematosus (SLE).

[Oncogenetics and molecular tumor boards in private practice: Specificities and perspectives].

Targeting TP53 in triple-negative breast cancer: Molecular pathogenesis, therapeutic implications, and emerging pharmacological strategies.

French treatment recommendations for malignant non-seminomatous germ cell tumours in children and adolescents.

A comprehensive review on the molecular basis and therapeutic potential of UBE2M in cancer.

Cervical cancer in French Guiana before the implementation of the University Hospital: Outcome and prognosis.

[Metastatic or unresectable recurrent anal canal cancer: Therapeutic approaches and emerging perspectives].

Clinical Efficacy of High-Frequency Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Depression and the Predictive Role of Baseline Triglyceride Levels: A Randomized Sham-Controlled Trial.

Mechanistic Basis and Therapeutic Potential of a Novel TXNIP Inhibitor in Diabetes Treatment.

Discovery of BRD9 PROTAC/IMiD Bifunctional Molecules as Potent Therapeutics for Hematologic Malignancies.

First line asciminib in chronic myeloid leukemia: a quest for the "Holy Grail" of tolerability.

Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition.

Repurposing MK0873 as a non-covalent hTERT-Targeting compound: a proof of concept study.

Related Experiment Videos

[Progress and results in the treatment of multiple myeloma]

Related Concept Videos

Related Articles